Research & Development

The Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) of the FDA, has invited PharmaMar to participate in this ODAC, giving a presentation to provide background information on Zepsyre™, positive clinical data obtained from phases I and II, in which a good tolerance and a good safety profile were observed, and to…
Attendees of FierceBiotech’s 2ndAnnual Drug Development Forum will obtain essential funding strategies and more productive R&D through executive-level networking opportunities. Convening at the Renaissance Boston Waterfront Hotel September 25–27, 2017, the conference draws together the industry’s top decision makers to help guide to success throughout the entire lifecycle — both…
Evoke Pharma Inc , a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases announced that it has entered into an agreement with Rho, Inc., a regulatory consulting and contract research organization (CRO). Rho will assist Evoke with the preparation and submission of its planned 505(b)(2) New Drug Application…
GE Healthcare announced that Dr. Reddy’s Laboratories Limited will install India’s first-ever FlexFactory, a single-use manufacturing platform to expand the biologics production capacity at its facility in Hyderabad, India.  FlexFactory will make Dr. Reddy’s biopharmaceutical manufacturing set-up more flexible and efficient, strengthening the company’s position in the global biosimilars market…
JSR Life Sciences (JLS), the global life sciences focused division of JSR Corporation, today announced plans for expansion of its production capabilities of Amsphere™ A3 protein-A chromatography resin at JSR’s Belgium subsidiary, JSR Micro NV. This expansion will effectively increase its production capacity by 6 times and provide all-important redundancy…
Page 1 of 27

Subscribe To Our Newsletter

Security Q:How many eyes has a typical person? (ex: 1)
Name:
Email: